New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
07:08 EDTQDEL, DGX, ABAX, IDXX, VIVO, EXASLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.
News For IDXX;DGX;EXAS;ABAX;QDEL;VIVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
09:25 EDTQDELLeerink life science tools analyst holds an analyst/industry conference call
Life Science Tools & Diagnostics Analyst Leonard, along with Dr. Anami Patel and Dr. Nathan Ledeboer, discuss their perspectives on Point-of-Care molecular tests including the opportunity in virology / microbiology, the threat to traditional lab-based testing and point-of-care instruments on an Analyst/Industry conference call to be held on July 30 at 11 am.
07:06 EDTIDXXIDEXX backs FY15 EPS view $2.07-$2.12, consensus $2.09
Backs FY15 revenue view $1.6B-$1.62B, consensus $1.60B. Backs FY15 CapEx view of $100M.
07:05 EDTIDXXIDEXX reports Q2 EPS 60c, consensus 57c
Subscribe for More Information
July 29, 2015
06:27 EDTDGXQuintiles sees Joint Venture with Quest Diagnostics neutral to EPS in FY15
Subscribe for More Information
July 28, 2015
11:36 EDTDGXQuest Diagnostics management to meet with SunTrust
Subscribe for More Information
July 24, 2015
10:00 EDTABAXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abaxis (ABAX) downgraded to Hold from Buy at Canaccord... Buffalo Wild Wings (BWLD) downgraded to Neutral from Buy at Dougherty... CF Industries (CF) downgraded on nitrogen outlook at RBC Capital... Capital One (COF) downgraded to Neutral from Overweight at JPMorgan... Cepheid (CPHD) downgraded to Sell from Hold at Evercore ISI... Constant Contact (CTCT) downgraded to Neutral from Outperform at Baird... Equifax (EFX) downgraded to Neutral from Outperform at Baird... Hannover Re (HVRRY) downgraded to Underweight from Neutral at JPMorgan... IAMGOLD (IAG) downgraded to Underperform from Market Perform at Raymond James... MSA Safety (MSA) downgraded to Neutral from Accumulate at Global Hunter... MTU Aero (MTUAY) downgraded to Underperform from Buy at BofA/Merrill... Macy's (M) downgraded to Underweight from Neutral at Atlantic Equities... Sunesis (SNSS) downgraded to Hold from Buy at Cantor... Superior Drilling (SDPI) downgraded to Hold from Buy at Wunderlich... TrueCar (TRUE) downgraded to Equal Weight from Overweight at Stephens... United Rentals (URI) downgraded to Outperform from Top Pick at RBC Capital... WESCO (WCC) downgraded to Equal Weight from Overweight at Stephens.
06:17 EDTABAXAbaxis downgraded to Hold from Buy at Canaccord
Subscribe for More Information
July 23, 2015
16:03 EDTABAXAbaxis reports Q1 EPS 31c, consensus 28c
Reports Q1 revenue $53.1M, consensus $53.82M.
10:00 EDTEXAS, IDXXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:56 EDTEXASExact Sciences upgraded to Buy from Hold at Lake Street
Lake Street Capital Markets analyst Bruce Jackson upgraded Exact Sciences to Buy and raised his price target for shares to $30 from $27. The company's Q2 report showed better than expected gross margins and the stock's risk/reward is appealing, Jackson tells investors.
08:34 EDTIDXXIDEXX upgraded to Hold from Sell at Feltl
Feltl upgraded IDEXX to Hold and increased its price target to $69.50 from $61.50 based on an improved growth outlook and valuation.
08:02 EDTVIVOMeridian Bioscience reaffirms FY15 EPS view 85c-91c, consensus 86c
Subscribe for More Information
08:02 EDTVIVOMeridian Bioscience reports Q3 EPS 22c, consensus 22c
Reports Q3 revenue $48.2M, consensus $48.6M.
07:28 EDTABAXAbaxis well positioned despite increased competition, says Canaccord
Subscribe for More Information
07:07 EDTDGXQuest Diagnostics backs FY15 adjusted EPS view $4.70-$4.85, consensus $4.73
Subscribe for More Information
07:05 EDTDGXQuest Diagnostics reports Q2 adjusted EPS $1.25, consensus $1.23
Reports Q2 revenue $1.93B, consensus $1.93B.
July 22, 2015
16:17 EDTQDELQuidel reports Q2 EPS (14c), consensus (25c)
Subscribe for More Information
15:26 EDTDGXNotable companies reporting before tomorrow's open
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use